Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-08 5:15 pm Purchase |
2022-07-29 | 13G | Zymeworks Inc. ZYME |
Redmile Group LLC | 5,758,241 9.900% |
5,758,241 (New Position) |
Filing History |
| 2022-07-18 5:16 pm Purchase |
2022-07-07 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 4,891,693 9.900% |
1,662,776 (+51.50%) |
Filing History |
| 2022-07-06 5:15 pm Purchase |
2022-07-01 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 933,483 50.700% |
282,353 (+43.36%) |
Filing History |
| 2022-06-27 5:16 pm Purchase |
2022-06-17 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 5,352,205 9.900% |
1,727,325 (+47.65%) |
Filing History |
| 2022-06-15 5:00 pm Unchanged |
2022-06-13 | 13D | Science 37 Holdings, Inc. SNCE |
Redmile Group LLC | 990,412 17.100% |
0 (Unchanged) |
Filing History |
| 2022-06-03 5:16 pm Purchase |
2022-05-24 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,199,363 9.900% |
3,199,363 (New Position) |
Filing History |
| 2022-05-09 5:15 pm Purchase |
2022-04-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 5,680,917 8.100% |
5,016,100 (+754.51%) |
Filing History |
| 2022-04-06 5:15 pm Purchase |
2022-04-04 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 651,130 41.800% |
423,529 (+186.08%) |
Filing History |
| 2022-04-05 5:09 pm Sale |
2022-04-01 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,362,460 12.900% |
-75,572 (-2.20%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
Redmile Group LLC | 1,602,285 4.600% |
-720,272 (-31.01%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 28,405,042 9.990% |
6,279,553 (+28.38%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 1,472,522 9.900% |
91,445 (+6.62%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Epizyme, Inc. EPZM |
Redmile Group LLC | 3,832,475 3.500% |
-6,392,930 (-62.52%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 19,621,981 8.500% |
9,093,802 (+86.38%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Redmile Group LLC | 1,820,898 7.300% |
145,862 (+8.71%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,816,196 10.900% |
-8,213 (-0.29%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Redmile Group LLC | 216,078 9.900% |
6,295 (+3.00%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 4,775,461 9.900% |
117,418 (+2.52%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 3,624,880 9.900% |
212,871 (+6.24%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Stereotaxis, Inc. STXS |
Redmile Group LLC | 7,308,325 9.100% |
-525,440 (-6.71%) |
Filing History |